About
Novel Therapeutics
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyChina
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
102
By Phase
PHASE1: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07167537Collaborator
A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases
PHASE1Recruiting
44 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
NCT06644118Collaborator
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
PHASE1Recruiting
58 participants
Started: Oct 23, 2024 · Completed: Oct 31, 2028
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...